Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
26.8M
-
Shares change
-
+7.05M
-
Total reported value, excl. options
-
$211M
-
Value change
-
+$56.7M
-
Put/Call ratio
-
0.12
-
Number of buys
-
27
-
Number of sells
-
-22
-
Price
-
$7.94
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q1 2020
84 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q1 2020.
AVADEL PHARMACEUTICALS - COM (AVDL) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.8M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.62M shares), Avoro Capital Advisors LLC (4.37M shares), Vivo Capital, LLC (3.58M shares), ACUTA CAPITAL PARTNERS, LLC (2.67M shares), BRANDES INVESTMENT PARTNERS, LP (1.64M shares), COWEN AND COMPANY, LLC (1.52M shares), VR Adviser, LLC (1.06M shares), RENAISSANCE TECHNOLOGIES LLC (906K shares), Invesco Ltd. (733K shares), and DEUTSCHE BANK AG\ (588K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.